MedCity News January 26, 2026
For many organizations, the workload has become too large for manual review alone. AI and automation are stepping in, not to replace the human element, but to restore focus to it.
For decades, drug safety has depended on one simple but demanding task: turning fragments of information from patients, physicians, and trials into clear signals that protect lives. Today, that responsibility sits at the center of a digital revolution. Artificial intelligence and automation are transforming pharmacovigilance from a manual, reactive discipline into one that is fast, predictive, and globally connected. The change is cultural, reshaping how safety professionals think, collaborate, and ensure trust in the medicines we all rely on.
Prior to technology-enabled process transformation, key activities of pharmacovigilance like...
Today's Sponsors
Today's Sponsor